15 - 21 July 2017
These are links to news stories from the last week that may be of interest to people in the UK. The link beneath each item will take you to the original story.
Please note that the MS Trust did not write the original items and does not endorse their content nor any claims made in them.
To keep up to date on all the latest news, views and research on multiple sclerosis, sign up for Open Door, our free newsletter or regular email alerts
Access to disease modifying drugs
Missing Pieces, a survey of MS health professionals (HPs) and people with MS by pharmaceutical company Sanofi, found that three quarters of HPs thought people with relapsing MS are facing delays in starting treatment with a disease modifying drug. The proportion of people on a drug is lower than most European countries. The lack of MS neurologists and facilities are listed as the main reasons for the delay.
MS Trust link: MS Decisions - a guide to the disease modifying drugs
The cost of MS
Protecting cognitive reserve
Research suggests nine lifestyle changes to reduce dementia related brain tissue loss and build up reserves that help the brain compensate for problems. Although the causes are quite different, these brain health factors also apply to protecting against build-up of cognition symptoms in MS
MS Trust link: Brain health
Vitamin D and bone health
A small Norwegian study found that people with MS taking a weekly 20,000 IU vitamin D supplement over two years showed no differences to bone mass density than a placebo group (though the results were compromised by half the people in the placebo group taking vitamin D supplement outside the study)
Source: Medical News Bulletin
MS Trust link: Vitamin D